tation was also reported in animal models of MPS VI to provide the deficient enzyme in order to correct some of the clinical manifestations. 2 However, allogeneic bone marrow Severe Maroteaux-Lamy syndrome is usually fatal in teenage or early adult life. Until recently, allogeneic transplant is associated with a significant procedure-related mortality and morbidity because of cytopenia and graftbone marrow transplantation was the only form of enzyme replacement. We report the first successful versus-host disease (GVHD). Recent experience with mobilised blood cell transplantation demonstrates more transplant using CD34 selected, mobilised allogeneic blood cells for an inborn error of metabolism. A busulrapid haemopoietic reconstitution 3 and CD34 selection has been shown to be an effective form of T cell depletion that phan, cyclophosphamide, melphalan and antithymocyte globulin conditioning regimen was used as myelomay reduce GVHD. We report the first successful CD34 selected allogeneic peripheral stem cell transplant for an ablative therapy. Allogeneic CD34 selected granulocyte colony-stimulating factor (G-CSF)-mobilised blood cells inborn error of metabolism. from a HLA-identical sibling were used for the transplant. Haemopoietic reconstitution occurred on day 10 post-transplant with normal N-acetylgalactosamine-4-Case report sulphatase levels. Infectious and graft-versus-host disease (GVHD) complications were minimal. We suggest A 12-year-old boy with Maroteaux-Lamy syndrome was referred for consideration of a bone marrow transplant. He that CD34 selected, mobilised allogeneic blood cells are a safe form of enzyme replacement therapy in Marowas initially diagnosed at the age of 18 months, with coarse facial features, normal developmental progress, mild fixed teaux-Lamy syndrome and should be considered in other metabolic diseases where the benefits of haemopoflexion deformity of knees and coarse skin. MaroteauxLamy syndrome was confirmed on demonstration of ietic transplantation are proven. Keywords: allogeneic stem cell transplantation; metadeficient N-acetylgalactosamine-4-sulphatase activity in both leucocytes and skin fibroblasts. bolic disease; GVHD During the following years, the clinical manifestations became more severe including obstructive hydrocephalus requiring ventriculo-peritoneal shunt, increasing joint conMucopolysaccharidosis VI (MPS VI), Maroteaux-Lamy tractures, recurrent discharging ears, significant hearing loss syndrome, is caused by deficiency of the enzyme N-acetylrequiring hearing aids, corneal clouding, carpal tunnel syngalactosamine-4-sulphatase, resulting in glycosaminoglydrome, mitral valve disease and increasing hepatosplenocan accumulation in most tissues. Individuals affected by megaly. The child continued to attend a normal school. In this disorder have multiple complications including bony June 1994, evidence of progressive airway obstruction, dysplasia, hepatosplenomegaly, airway narrowing, cardiac including snoring and daytime somnolence, became apparvalvular deposition, and deposition in their subcutaneous ent. Overnight oximetry confirmed significant hypoxia tissues. However, unlike most of the other mucopolysacchdesaturating to 80% during REM sleep, with desaturations aridoses, patients with Maroteaux-Lamy syndrome have a which were prolonged in nature and which were reversed normal intellect. Patients with severe disease usually die in with continuous positive airway pressure (C-PAP brother as a means of enzyme replacement therapy.
The patient had a long past history of chronic discharging tension requiring anti-hypertensive medication on day +80. His hypertension was probably due to fluid overload ears colonised with Pseudomonas aeruginosa and Streptococcus pneumoniae. During a standard allogeneic bone secondary to cyclosporin A. Cyclosporin A was stopped at 6 months post-transplant. N-acetylgalactosamine-4-sulmarrow transplant the risk of infection, especially pulmonary infection during the cytopenic period, is considerable.
phatase was measured pre-and post-peripheral stem cell transplant as shown in Table 1 . Chronic otitis media is an additional source of infection. GVHD and its immunosuppressive therapy adds further A clinical review performed 6 months after transplantation revealed his C-PAP requirement at night had fallen risks. However, the greatest concern was the danger of complete obstruction of an already compromised airway.
from 12 cm water to 8 cm of water although there was no objective evidence of reduction in airway calibre on CT An allogeneic stem cell transplant with CD34 selection was discussed with the family, following which parental inforscan. His liver was just palpable below the costal margin, having been 10 cm below the right costal margin before med consent was obtained. Ethics Committee approval was also sought and granted. The donor received 10 g/kg of transplant, and spleen was not palpable by deep palpation having been palpable 8 cm below the left costal margin Filgrastim (Amgen, Thousand Oaks, CA, USA) subcutaneously for 3 days and harvested using peripheral venous prior to transplant. Clinically, the coarseness of his skin reduced significantly and his chronic otorrhoea had comaccess on 2 consecutive days. On day 4, peripheral blood mononuclear cells were harvested using a continuous flow pletely resolved. Further clinical assessment including echocardiogram and repeat CT scan of his airways will be blood cell separator (Fenwal CS 3000 plus; Baxter, Deerfield, IL, USA). 556.9 × 10 8 mononuclear cells were harperformed 12 months post-transplant. vested. CD34 selection was performed using the Baxter Isolex 300SA Cell Selection System (Baxter Healthcare) according to the manufacturer's instructions. After CD34 Discussion selection, 404.55 × 10 6 cells were cryopreserved consisting of 386.71 × 10 6 CD34 cells and 4.05 × 10 6 T lymphocytes. The available therapeutic options for management of severe airway obstruction in mucopolysaccharide storage diseases On day 5, 498.8 × 10 8 mononuclear cells were harvested, and stored as back-up. They were not CD34 selected.
are limited. Reversal of accumulated storage material requires enzyme replacement therapy, either by direct The child's preparative regimen consisted of busulphan 4 mg/kg p.o. in divided doses daily for 4 days on days −8 administration of the enzyme or bone marrow transplantation. Tracheostomy may provide a temporary relief of to −5, cyclophosphamide 60 mg/kg/day i.v. over 6 h on days −4 and −3, melphalan 90 mg/m 2 i.v. for 1 h on day obstruction, but there is no effect on disease progression. In addition, the redundant folds of MPS-infiltrated tissue −2 and antithymocyte globulin (ATG) Fresenius 4 mg/kg i.v. alternate daily three times during conditioning. GVHD cause such extreme narrowing of the tracheal lumen that, even with a fenestrated tracheostomy tube, speech is not prophylaxis consisted of cyclosporin A and three doses of methotrexate (10 mg/m 2 /dose i.v. on days +1, +3 and +6).
possible. Successful enzyme replacement therapy has been demonFilgrastim was started on the day of transplant and continued until day 12, when his neutrophil count was greater strated, in MPS VI-affected cats, using both bone marrow transplantation and more recently, purified human enzyme. 6 Bone marrow transplantation is the only complicated by mild mucositis and increasing respiratory difficulty, presumed to be due to oedema of the trachea available option for reversal of upper airway obstruction. Allogeneic transplants using G-CSF-mobilised blood overlying his narrowed airway, which responded to increased C-PAP. He was started on ceftazidime and tobracells have been shown to produce rapid haemopoietic mycin on day +4 when his temperature was 37.5°C and his neutrophil count was less than 0.5 × 10 9 /l. No bacteria were GVHD. CD34 cell selection produces a 2-4 log T cell 177-186. depletion. The combined approach of CD34 selection and
